Stockreport

Nurix Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modula [Read more]